Drug Side Effects
Search
MATERNAL EXPOSURE VIA PARTNER DURING PREGNANCY
MATERNAL EXPOSURE VIA PARTNER DURING PREGNANCY
was reported 64 times
These drug classes are most commonly taken by patients reporting MATERNAL EXPOSURE VIA PARTNER DURING PREGNANCY:
#
Drug
Count
0
Interleukin-17A Antagonist [EPC]
6
1
Programmed Death Receptor-1 Blocking Antibody [EPC]
6
2
CD20-directed Cytolytic Antibody [EPC]
5
3
Thyroid Hormone Receptor beta Agonist [EPC]
5
4
Corticosteroid [EPC]
4
5
Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]
3
6
Nucleoside Metabolic Inhibitor [EPC]
3
7
Vascular Endothelial Growth Factor Inhibitor [EPC]
3
8
Atypical Antipsychotic [EPC]
2
9
CD22-directed Immunoconjugate [EPC]
2
10
Epidermal Growth Factor Receptor Antagonist [EPC]
2
11
Folate Analog Metabolic Inhibitor [EPC]
2
12
Interleukin-17 Receptor A Antagonist [EPC]
2
13
Kinase Inhibitor [EPC]
2
14
Nucleoside Analog Antiviral [EPC]
2
15
Platinum-based Drug [EPC]
2
16
Tumor Necrosis Factor Blocker [EPC]
2
17
5-alpha Reductase Inhibitor [EPC]
1
18
Alkylating Drug [EPC]
1
19
Angiotensin 2 Receptor Blocker [EPC]
1
20
Antimetabolite Immunosuppressant [EPC]
1
21
Asparagine-specific Enzyme [EPC]
1
22
Dihydropyridine Calcium Channel Blocker [EPC]
1
23
GLP-1 Receptor Agonist [EPC]
1
24
Histamine-1 Receptor Antagonist [EPC]
1
25
Integrin Receptor Antagonist [EPC]
1
26
Interleukin-4 Receptor alpha Antagonist [EPC]
1
27
Proton Pump Inhibitor [EPC]
1
28
Thalidomide Analog [EPC]
1
29
Vitamin B12 [EPC]
1
30
Vitamin C [EPC]
1
31
Vitamin D [EPC]
1
32
Xanthine Oxidase Inhibitor [EPC]
1